{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-294445","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2026-07-02T20:00:15+00:00","discovered_at":"2026-07-02T20:01:00.275154+00:00","generated_at":"2026-07-02T20:01:06.179910+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CMS withdraws Medicare billing changes for Orthofix bone growth stimulators; reimbursement restored to prior rates","bullets":["On July 1, 2026, CMS issued revised guidance withdrawing May 18, 2026 billing changes for HCPCS codes E0747, E0748, E0760.","Orthofix expects average Medicare reimbursement for these codes to return to rates in effect prior to May 18, 2026.","The reversal follows FDA's April 16, 2026 reclassification of non-invasive bone growth stimulators from Class III to Class II.","The prior CMS changes had modified billing requirements and Medicare fee schedule treatment; now withdrawn."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-294445","json":"https://secwatch.observer/filing/0001193125-26-294445.json","markdown":"https://secwatch.observer/filing/0001193125-26-294445.md","text":"https://secwatch.observer/filing/0001193125-26-294445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000119312526294445/0001193125-26-294445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000119312526294445/ofix-20260701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:01:06.179910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}